Bristol-Myers Squibb Co. v. Superior Court: Federal District Courts Begin Weighing In

In June 2017, the Supreme Court issued its decision in Bristol-Myers Squibb Co. v. Superior Court, 137 S. Ct. 1773 (2017), which concerned personal jurisdiction over nonresident defendants for claims brought by nonresident plaintiffs in a California state court mass tort action. In the wake of the Bristol-Myers decision, the case law has been rapidly developing in the district courts in putative class actions where, in reliance on Bristol-Myers, defendants have challenged the courts’ jurisdiction where nonresident plaintiffs assert claims against nonresident defendants not subject to general jurisdiction.